Showing 15,281 - 15,300 results of 103,692 for search '(( 50 we decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.64s Refine Results
  1. 15281
  2. 15282
  3. 15283

    Effects of forced Elf5 expression on tumor growth and cell autonomous pro-tumorigenic traits. by David Gallego-Ortega (107516)

    Published 2016
    “…<p><b>Panel A</b>, PyMT mammary tumors showing heterogeneous expression of ELF5 visualized by EGFP expression. …”
  4. 15284

    EBNA3C down-regulated RASSF1A mRNA expression by enhancing RASSF1A promoter methylation. by Shengwei Zhang (321384)

    Published 2019
    “…<p>(A-D) RASSF1A mRNA expression was decreased in A-B) EBV positive cell lines and C-D) BJAB7, BJAB10, LCL1, and LCL2 cells. 5 million B-cells were collected and total RNA extracted via Trizol reagent. cDNAs were generated by reverse transcriptase kit and RASSF1A mRNA expression level was detected by real-time PCR. …”
  5. 15285

    A Family of Binuclear Dysprosium(III) Radical Compounds with Magnetic Relaxation in ON and OFF States by Tian Han (1674109)

    Published 2012
    “…The adduct ([Dy­(hfac)<sub>3</sub>(PyNONIT)]<sub>2</sub>[Dy<sub>0.5</sub>(hfac)<sub>1.5</sub>(H<sub>2</sub>O)]<sub>2</sub>) (<b>3</b>) consists of two items, the dimer [Dy­(hfac)<sub>3</sub>(PyNONIT)]<sub>2</sub> and the monomer [Dy­(hfac)<sub>3</sub>(H<sub>2</sub>O)<sub>2</sub>], where the symmetry of Dy<sup>III</sup> ion in Dy<sub>2</sub>O<sub>2</sub> decreases to <i>D</i><sub>2<i>d</i></sub>, showing slow relaxation of the magnetization at lower temperature. …”
  6. 15286

    Electrochemical, Computational, and Photophysical Characterization of New Luminescent Dirhenium–Pyridazine Complexes Containing Bridging OR or SR Anions by Alessio Raimondi (2108038)

    Published 2012
    “…A series of [Re<sub>2</sub>(μ-ER)<sub>2</sub>(CO)<sub>6</sub>(μ-pydz)] complexes have been synthesized (E = S, R = C<sub>6</sub>H<sub>5</sub>, <b>2</b>; E = O, R = C<sub>6</sub>F<sub>5</sub>, <b>3</b>; C<sub>6</sub>H<sub>5</sub>, <b>4</b>; CH<sub>3</sub>, and <b>5</b>; H, <b>6</b>), starting either from [Re­(CO)<sub>5</sub>O<sub>3</sub>SCF<sub>3</sub>] (for <b>2</b> and <b>4</b>), [Re<sub>2</sub>(μ-OR)<sub>3</sub>(CO)<sub>6</sub>]<sup>−</sup> (for <b>3</b> and <b>5</b>), or [Re<sub>4</sub>(μ<sub>3</sub>-OH)<sub>4</sub>(CO)<sub>12</sub>] (for <b>6</b>). …”
  7. 15287

    Electrochemical, Computational, and Photophysical Characterization of New Luminescent Dirhenium–Pyridazine Complexes Containing Bridging OR or SR Anions by Alessio Raimondi (2108038)

    Published 2012
    “…A series of [Re<sub>2</sub>(μ-ER)<sub>2</sub>(CO)<sub>6</sub>(μ-pydz)] complexes have been synthesized (E = S, R = C<sub>6</sub>H<sub>5</sub>, <b>2</b>; E = O, R = C<sub>6</sub>F<sub>5</sub>, <b>3</b>; C<sub>6</sub>H<sub>5</sub>, <b>4</b>; CH<sub>3</sub>, and <b>5</b>; H, <b>6</b>), starting either from [Re­(CO)<sub>5</sub>O<sub>3</sub>SCF<sub>3</sub>] (for <b>2</b> and <b>4</b>), [Re<sub>2</sub>(μ-OR)<sub>3</sub>(CO)<sub>6</sub>]<sup>−</sup> (for <b>3</b> and <b>5</b>), or [Re<sub>4</sub>(μ<sub>3</sub>-OH)<sub>4</sub>(CO)<sub>12</sub>] (for <b>6</b>). …”
  8. 15288

    Synthesis and Cyclic Voltammetric Studies of the Diiron Complexes ER<sub>2</sub>[(η<sup>5</sup>-C<sub>5</sub>H<sub>4</sub>)Fe(L<sub>2</sub>)Me]<sub>2</sub> (E = C, Si, Ge, Sn; R =... by Mukesh Kumar (132604)

    Published 2008
    “…Cyclic voltammetric studies on ER<sub>2</sub>[(η<sup>5</sup>-C<sub>5</sub>H<sub>4</sub>)Fe(L<sub>2</sub>)Me]<sub>2</sub> (L<sub>2</sub> = dppe; ER<sub>2</sub><i></i> = CH<sub>2</sub> (<b>1a</b>), SiMe<sub><i>2</i></sub> (<b>2a</b>), GeMe<sub>2</sub> (<b>3a</b>), SnMe<sub>2</sub> (<b>4a</b>)) revealed two well-resolved reversible waves (<sup>1</sup><i>E</i><sub>1/2</sub> = −0.33 V, <sup>2</sup><i>E</i><sub>1/2</sub> = −0.20 V (for <b>1a</b>); <sup>1</sup><i>E</i><sub>1/2</sub> = −0.35 V, <sup>2</sup><i>E</i><sub>1/2</sub> = −0.21 V (for<i></i> <b>2a</b>); <sup>1</sup><i>E</i><sub>1/2</sub> = −0.36 V, <sup>2</sup><i>E</i><sub>1/2</sub> = −0.23 V (for <b>3a</b>); <sup>1</sup><i>E</i><sub>1/2</sub> = −0.36 V, <sup>2</sup><i>E</i><sub>1/2</sub> = −0.22 V (for <b>4a</b>)) in CH<sub>2</sub>Cl<sub>2</sub>, suggesting electronic communication between two iron centers, which is seen for the first time in this family of organometallic complexes. …”
  9. 15289

    Synthesis and Cyclic Voltammetric Studies of the Diiron Complexes ER<sub>2</sub>[(η<sup>5</sup>-C<sub>5</sub>H<sub>4</sub>)Fe(L<sub>2</sub>)Me]<sub>2</sub> (E = C, Si, Ge, Sn; R =... by Mukesh Kumar (132604)

    Published 2008
    “…Cyclic voltammetric studies on ER<sub>2</sub>[(η<sup>5</sup>-C<sub>5</sub>H<sub>4</sub>)Fe(L<sub>2</sub>)Me]<sub>2</sub> (L<sub>2</sub> = dppe; ER<sub>2</sub><i></i> = CH<sub>2</sub> (<b>1a</b>), SiMe<sub><i>2</i></sub> (<b>2a</b>), GeMe<sub>2</sub> (<b>3a</b>), SnMe<sub>2</sub> (<b>4a</b>)) revealed two well-resolved reversible waves (<sup>1</sup><i>E</i><sub>1/2</sub> = −0.33 V, <sup>2</sup><i>E</i><sub>1/2</sub> = −0.20 V (for <b>1a</b>); <sup>1</sup><i>E</i><sub>1/2</sub> = −0.35 V, <sup>2</sup><i>E</i><sub>1/2</sub> = −0.21 V (for<i></i> <b>2a</b>); <sup>1</sup><i>E</i><sub>1/2</sub> = −0.36 V, <sup>2</sup><i>E</i><sub>1/2</sub> = −0.23 V (for <b>3a</b>); <sup>1</sup><i>E</i><sub>1/2</sub> = −0.36 V, <sup>2</sup><i>E</i><sub>1/2</sub> = −0.22 V (for <b>4a</b>)) in CH<sub>2</sub>Cl<sub>2</sub>, suggesting electronic communication between two iron centers, which is seen for the first time in this family of organometallic complexes. …”
  10. 15290

    Merkel Cell Polyomavirus Small T Antigen Promotes Pro-Glycolytic Metabolic Perturbations Required for Transformation by Christian Berrios (127454)

    Published 2016
    “…While MYC was required for MCT1 induction, MCPyV-induced MCT1 levels decreased following knockdown of the NF-κB subunit RelA, supporting a synergistic activity between MCPyV and MYC in regulating MCT1 levels. …”
  11. 15291

    The data of meta-analysis. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  12. 15292

    Quality assessment for risk of bias for studies. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  13. 15293

    Effect of tirzepatide vs placebo on body weight. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  14. 15294

    The results of safety in meta-analysis. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  15. 15295

    Graphs of risk of bias for studies. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  16. 15296

    General baseline of included studies. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  17. 15297
  18. 15298

    IQGAP1 is a protein that plays a critical role in regulating the level of apoptosis in endothelial cells. by Shaojun Huang (12489901)

    Published 2025
    “…<p>(A) The Annexin V–FITC/propidium iodide (PI) assay results indicate that Si-IQGAP1 can slightly decrease the apoptosis rate of normal cells, whereas knocking down IQGAP1 in PA-induced cells (PA + Si-IQGAP1) can significantly reduce the apoptosis rate. …”
  19. 15299
  20. 15300